Effect of acyclovir on thermal stress-induced herpesvirus reactivation
- PMID: 15512960
- DOI: 10.1080/02713680490504560
Effect of acyclovir on thermal stress-induced herpesvirus reactivation
Abstract
Purpose: Acyclovir has been shown to be effective in preventing recurrent herpes simplex virus lesions of the genitalia and oral labia. The purpose of the current study was to determine the effect of acyclovir on the appearance of infectious virus in the peripheral nervous system and in an end organ, the eye.
Materials and methods: Mice latent for the McKrae strain of herpes simplex virus type 1 were given 3.5 mg/ml acyclovir in their drinking water. Control animals received water without drug. Acyclovir treatment was continued for 4 successive days. On the third day, the mice were subjected to a brief period of hyperthermic stress to induce viral reactivation. Twenty-four hours after stress induction, swabs of the ocular surface and homogenates of the cornea and trigeminal ganglia were analyzed for the presence of infectious herpes simplex virus type 1 and viral DNA.
Results: Acyclovir treatment significantly decreased the frequency of infectious virus in the ocular tear film and the cornea but not in the trigeminal ganglion. The corneal homogenates of acyclovir-treated animals contained smaller amounts of viral DNA compared with untreated controls, whereas the amounts of viral DNA in the trigeminal ganglia of acyclovir-treated and untreated animals were similar.
Conclusions: These results suggest that oral administration of acyclovir, at least at the dose used in this study, is effective in modestly reducing viral replication in peripheral tissues such as the eye but is not effective in inhibiting viral reactivation and viral DNA synthesis in the peripheral nervous system in mice subjected to induction of reactivation by hyperthermic stress.
Similar articles
-
Acetylsalicylic acid reduces viral shedding induced by thermal stress.Curr Eye Res. 2004 Aug-Sep;29(2-3):119-25. doi: 10.1080/02713680490504588. Curr Eye Res. 2004. PMID: 15512958
-
Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3459-65. Invest Ophthalmol Vis Sci. 1993. PMID: 8225880
-
A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.J Infect Dis. 1999 Sep;180(3):821-3. doi: 10.1086/314958. J Infect Dis. 1999. PMID: 10438371
-
[Battle with herpes for 37 years].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):145-66; discussion 167. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854108 Review. Japanese.
-
[Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):247-64; discussion 265. Nippon Ganka Gakkai Zasshi. 2008. PMID: 18411713 Review. Japanese.
Cited by
-
Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.J Biomed Biotechnol. 2012;2012:612316. doi: 10.1155/2012/612316. Epub 2012 Oct 2. J Biomed Biotechnol. 2012. PMID: 23091352 Free PMC article. Review.
-
New concepts in herpes simplex virus vaccine development: notes from the battlefield.Expert Rev Vaccines. 2009 Aug;8(8):1023-35. doi: 10.1586/erv.09.60. Expert Rev Vaccines. 2009. PMID: 19627185 Free PMC article. Review.
-
Herpetic Keratitis Recurred after the Use of a Thermal Medical Device: A Case Report.Korean J Ophthalmol. 2022 Feb;36(1):78-79. doi: 10.3341/kjo.2021.0015. Epub 2021 Nov 26. Korean J Ophthalmol. 2022. PMID: 34823338 Free PMC article. No abstract available.
-
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Future Microbiol. 2011 Aug;6(8):877-907. doi: 10.2217/fmb.11.73. Future Microbiol. 2011. PMID: 21861620 Free PMC article. Review.
-
Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.Invest Ophthalmol Vis Sci. 2011 Mar 28;52(3):1770-9. doi: 10.1167/iovs.09-5019. Print 2011 Mar. Invest Ophthalmol Vis Sci. 2011. PMID: 20881297 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical